Palvella Therapeutics (PVLA) Receivables - Net: 2013-2024
Historic Receivables - Net for Palvella Therapeutics (PVLA) over the last 8 years, with Sep 2024 value amounting to $500,000.
- Palvella Therapeutics' Receivables - Net fell 52.15% to $500,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $500,000, marking a year-over-year decrease of 52.15%. This contributed to the annual value of $5.8 million for FY2022, which is 75.37% up from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Receivables - Net is $500,000, which was down 66.33% from $1.5 million recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Receivables - Net peaked at $17.0 million during Q2 2021, and registered a low of $500,000 during Q3 2024.
- For the 3-year period, Palvella Therapeutics' Receivables - Net averaged around $1.6 million, with its median value being $1.2 million (2022).
- In the last 5 years, Palvella Therapeutics' Receivables - Net skyrocketed by 477.45% in 2021 and then plummeted by 95.12% in 2022.
- Quarterly analysis of 5 years shows Palvella Therapeutics' Receivables - Net stood at $1.7 million in 2020, then spiked by 94.20% to $3.3 million in 2021, then spiked by 75.37% to $5.8 million in 2022, then climbed by 26.06% to $1.0 million in 2023, then plummeted by 52.15% to $500,000 in 2024.
- Its Receivables - Net was $500,000 in Q3 2024, compared to $1.5 million in Q2 2024 and $1.8 million in Q1 2024.